R&D Overview

The developmental vision of the company is to deliver innovative therapies that treat and prevent disorders of the Ears, Nose and Throat.  We currently have two novel programs:

  • Foam platform (OP-01) for use in outer ear, nose, and sinus
  • Surfactant pharmaceutical product (OP-02) for use in middle and inner ear

Currently, these programs are in development to prevent and treat disorders of the Ear, including Otitis Externa and Otitis Media.